syndrome	score	normalized_score
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.0	100.0
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	100.0
ULNAR HEMIMELIA	0.5	50.0
PANNER DISEASE	0.5	50.0
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14350888999999997	14.350888999999997
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14350888999999997	14.350888999999997
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.14350888999999997	14.350888999999997
AUTOIMMUNE HYPOPARATHYROIDISM	0.14285699999999998	14.285699999999999
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	14.285699999999999
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	14.285699999999999
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	14.285699999999999
16P13.2 MICRODELETION SYNDROME	0.04196849	4.196848999999999
AL AMYLOIDOSIS	0.03381709	3.3817090000000003
WILLIAMS-BEUREN SYNDROME; WBS	0.03363512	3.3635119999999996
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.03363512	3.3635119999999996
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	3.2983229999999994
300270 ADRENOMYODYSTROPHY	0.032983229999999995	3.2983229999999994
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.032983229999999995	3.2983229999999994
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.030942360000000002	3.0942360000000004
EPIDERMAL NEVUS SYNDROME	0.030942360000000002	3.0942360000000004
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.030942360000000002	3.0942360000000004
ADNP SYNDROME	0.030063689999999997	3.006369
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.030063689999999997	3.006369
7Q11.23 MICRODUPLICATION SYNDROME	0.030063689999999997	3.006369
HOLMES-GANG SYNDROME	0.030063689999999997	3.006369
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.030063689999999997	3.006369
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.030063689999999997	3.006369
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.030063689999999997	3.006369
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.030063689999999997	3.006369
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.0294118	2.9411799999999997
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0294118	2.9411799999999997
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.0294118	2.9411799999999997
16P12.1P12.3 TRIPLICATION SYNDROME	0.0294118	2.9411799999999997
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0294118	2.9411799999999997
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	2.9411799999999997
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.0294118	2.9411799999999997
PITT-HOPKINS-LIKE SYNDROME	0.0294118	2.9411799999999997
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0294118	2.9411799999999997
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0294118	2.9411799999999997
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0294118	2.9411799999999997
TURNPENNY-FRY SYNDROME; TPFS	0.0294118	2.9411799999999997
RAMOS-ARROYO SYNDROME	0.0294118	2.9411799999999997
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	2.9411799999999997
CURRY-JONES SYNDROME	0.0294118	2.9411799999999997
QAZI-MARKOUIZOS SYNDROME	0.0294118	2.9411799999999997
DISTAL 16P11.2 MICRODELETION SYNDROME	0.0294118	2.9411799999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0294118	2.9411799999999997
CURRARINO SYNDROME	0.0294118	2.9411799999999997
VULVOVAGINAL GINGIVAL SYNDROME	0.027777800000000002	2.7777800000000004
RETINAL CAPILLARY MALFORMATION	0.027777800000000002	2.7777800000000004
OSTEOSARCOMA	0.027777800000000002	2.7777800000000004
ACATALASEMIA	0.027777800000000002	2.7777800000000004
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.027777800000000002	2.7777800000000004
PRIMARY HYPEROXALURIA TYPE 3	0.027777800000000002	2.7777800000000004
ANAPLASTIC THYROID CARCINOMA	0.027777800000000002	2.7777800000000004
TUFTED ANGIOMA	0.027777800000000002	2.7777800000000004
HEREDITARY PAINFUL CALLOSITIES	0.027777800000000002	2.7777800000000004
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.027777800000000002	2.7777800000000004
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.027777800000000002	2.7777800000000004
OROMANDIBULAR DYSTONIA	0.027777800000000002	2.7777800000000004
AMYOTROPHIC LATERAL SCLEROSIS	0.027777800000000002	2.7777800000000004
BUERGER DISEASE	0.027777800000000002	2.7777800000000004
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.027777800000000002	2.7777800000000004
O'SULLIVAN-MCLEOD SYNDROME	0.027777800000000002	2.7777800000000004
SPINOCEREBELLAR ATAXIA TYPE 43	0.027777800000000002	2.7777800000000004
POEMS SYNDROME	0.027777800000000002	2.7777800000000004
SUBEPENDYMOMA	0.027777800000000002	2.7777800000000004
THYROID LYMPHOMA	0.027777800000000002	2.7777800000000004
EPENDYMOMA	0.027777800000000002	2.7777800000000004
FIBULAR HEMIMELIA	0.027777800000000002	2.7777800000000004
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.027777800000000002	2.7777800000000004
INTERSTITIAL CYSTITIS	0.027777800000000002	2.7777800000000004
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.027777800000000002	2.7777800000000004
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.027777800000000002	2.7777800000000004
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.027777800000000002	2.7777800000000004
INFANTILE DIGITAL FIBROMATOSIS	0.027777800000000002	2.7777800000000004
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.027777800000000002	2.7777800000000004
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.027777800000000002	2.7777800000000004
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.027777800000000002	2.7777800000000004
CLUSTER HEADACHE, FAMILIAL	0.027777800000000002	2.7777800000000004
CLASSICAL EHLERS-DANLOS SYNDROME	0.020960049999999997	2.096005
MICROFORM HOLOPROSENCEPHALY	0.020960049999999997	2.096005
SILVER-RUSSELL SYNDROME	0.01703197	1.703197
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.016961979999999998	1.6961979999999999
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.01631009	1.631009
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.01631009	1.631009
SYSTEMIC MASTOCYTOSIS	0.01631009	1.631009
YAO SYNDROME	0.01631009	1.631009
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.01631009	1.631009
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.01612812	1.612812
49,XXXXY SYNDROME	0.01612812	1.612812
22Q11.2 DELETION SYNDROME	0.01612812	1.612812
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.015476229999999999	1.547623
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.015476229999999999	1.547623
48,XXYY SYNDROME	0.015476229999999999	1.547623
9Q33.3Q34.11 MICRODELETION SYNDROME	0.015476229999999999	1.547623
48,XXXY SYNDROME	0.015476229999999999	1.547623
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.015476229999999999	1.547623
CINCA SYNDROME	0.012808650000000001	1.2808650000000001
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.012626680000000001	1.2626680000000001
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.012626680000000001	1.2626680000000001
FG SYNDROME TYPE 1	0.012626680000000001	1.2626680000000001
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.012626680000000001	1.2626680000000001
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.012626680000000001	1.2626680000000001
JACOBSEN SYNDROME	0.012626680000000001	1.2626680000000001
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012626680000000001	1.2626680000000001
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.012626680000000001	1.2626680000000001
STÜVE-WIEDEMANN SYNDROME	0.012556689999999999	1.255669
CASPASE 8 DEFICIENCY	0.012556689999999999	1.255669
OCULO-PALATO-CEREBRAL SYNDROME	0.012556689999999999	1.255669
MYOTONIA PERMANENS	0.012556689999999999	1.255669
DUBOWITZ SYNDROME	0.012556689999999999	1.255669
BRAIN-LUNG-THYROID SYNDROME	0.012556689999999999	1.255669
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012556689999999999	1.255669
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.012556689999999999	1.255669
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.012556689999999999	1.255669
CHROMOSOME 18Q DELETION SYNDROME	0.012556689999999999	1.255669
ALSTROM SYNDROME; ALMS	0.012556689999999999	1.255669
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.012556689999999999	1.255669
IMMUNODEFICIENCY 58; IMD58	0.012556689999999999	1.255669
ALSTRÖM SYNDROME	0.012556689999999999	1.255669
NETHERTON SYNDROME	0.012556689999999999	1.255669
PGM3-CDG	0.012556689999999999	1.255669
SECKEL SYNDROME 9; SCKL9	0.012556689999999999	1.255669
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012556689999999999	1.255669
PELIZAEUS-MERZBACHER DISEASE	0.012219810000000001	1.2219810000000002
ZELLWEGER SYNDROME	0.012219810000000001	1.2219810000000002
EMANUEL SYNDROME	0.01197479	1.1974790000000002
KAGAMI-OGATA SYNDROME	0.01197479	1.1974790000000002
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01197479	1.1974790000000002
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	1.1904799999999998
PRIMARY PULMONARY HYPOPLASIA	0.011904799999999998	1.1904799999999998
47,XYY SYNDROME	0.011904799999999998	1.1904799999999998
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	1.1904799999999998
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	1.1904799999999998
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.011904799999999998	1.1904799999999998
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	1.1904799999999998
ICHTHYOSIS VULGARIS	0.011904799999999998	1.1904799999999998
BARDET-BIEDL SYNDROME 1; BBS1	0.011904799999999998	1.1904799999999998
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.011904799999999998	1.1904799999999998
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	1.1904799999999998
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	1.1904799999999998
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.011904799999999998	1.1904799999999998
CYSTIC FIBROSIS	0.011904799999999998	1.1904799999999998
PRIMARY CILIARY DYSKINESIA	0.011904799999999998	1.1904799999999998
BERNARD-SOULIER SYNDROME	0.011904799999999998	1.1904799999999998
CUTANEOUS MASTOCYTOSIS	0.011904799999999998	1.1904799999999998
48,XYYY SYNDROME	0.011904799999999998	1.1904799999999998
TRANSALDOLASE DEFICIENCY	0.011904799999999998	1.1904799999999998
MASTOCYTOSIS	0.011904799999999998	1.1904799999999998
NETHERTON SYNDROME; NETH	0.011904799999999998	1.1904799999999998
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	1.1904799999999998
DERMATITIS, ATOPIC	0.011904799999999998	1.1904799999999998
MUCOPOLYSACCHARIDOSIS, TYPE II	0.011904799999999998	1.1904799999999998
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	1.1904799999999998
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	1.1904799999999998
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.011904799999999998	1.1904799999999998
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	1.1904799999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.011904799999999998	1.1904799999999998
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	1.1904799999999998
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.011904799999999998	1.1904799999999998
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.011904799999999998	1.1904799999999998
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	1.1904799999999998
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	1.1904799999999998
AORTIC ARCH DEFECTS	0.011904799999999998	1.1904799999999998
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.011904799999999998	1.1904799999999998
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	1.1904799999999998
CARCINOID SYNDROME	0.011904799999999998	1.1904799999999998
IMMUNODEFICIENCY 23; IMD23	0.011904799999999998	1.1904799999999998
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	1.1904799999999998
CHILBLAIN LUPUS	0.011904799999999998	1.1904799999999998
WILLIAMS SYNDROME	0.01179317	1.179317
CONGENITAL TOXOPLASMOSIS	0.01156792	1.156792
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.01156792	1.156792
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00905525	0.9055250000000001
FATCO SYNDROME	0.00905525	0.9055250000000001
VASCULAR EHLERS-DANLOS SYNDROME	0.00905525	0.9055250000000001
COSTELLO SYNDROME; CSTLO	0.00905525	0.9055250000000001
CARDIOFACIOCUTANEOUS SYNDROME	0.00905525	0.9055250000000001
VELO-FACIAL-SKELETAL SYNDROME	0.00905525	0.9055250000000001
TEMPLE SYNDROME	0.00905525	0.9055250000000001
TYSHCHENKO SYNDROME	0.00905525	0.9055250000000001
DISTAL MONOSOMY 17Q	0.00905525	0.9055250000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00905525	0.9055250000000001
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00905525	0.9055250000000001
DISTAL MONOSOMY 10Q	0.00905525	0.9055250000000001
ROIFMAN SYNDROME; RFMN	0.00905525	0.9055250000000001
GALLOWAY-MOWAT SYNDROME	0.00905525	0.9055250000000001
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00905525	0.9055250000000001
TEMPLE SYNDROME	0.00905525	0.9055250000000001
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00905525	0.9055250000000001
GMS SYNDROME	0.00905525	0.9055250000000001
DIAMOND-BLACKFAN ANEMIA 1	0.00905525	0.9055250000000001
CORNEODERMATOOSSEOUS SYNDROME	0.00905525	0.9055250000000001
CORNELIA DE LANGE SYNDROME	0.00905525	0.9055250000000001
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00905525	0.9055250000000001
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00905525	0.9055250000000001
NEMALINE MYOPATHY 10	0.00840336	0.8403360000000001
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8403360000000001
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.8403360000000001
BECKWITH-WIEDEMANN SYNDROME	0.00840336	0.8403360000000001
SCHISIS ASSOCIATION	0.00840336	0.8403360000000001
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.8403360000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.8403360000000001
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.8403360000000001
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.8403360000000001
GAUCHER DISEASE, PERINATAL LETHAL	0.00840336	0.8403360000000001
PEMPHIGOID GESTATIONIS	0.00840336	0.8403360000000001
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.8403360000000001
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.8403360000000001
ROBERTS SYNDROME	0.00840336	0.8403360000000001
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8403360000000001
RETINOPATHY OF PREMATURITY	0.00840336	0.8403360000000001
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.8403360000000001
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.8403360000000001
ADAMS-OLIVER SYNDROME	0.00840336	0.8403360000000001
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.8403360000000001
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.8403360000000001
RENAL TUBULAR DYSGENESIS	0.00840336	0.8403360000000001
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.8403360000000001
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.8403360000000001
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00840336	0.8403360000000001
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.8403360000000001
KAGAMI-OGATA SYNDROME	0.00840336	0.8403360000000001
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00840336	0.8403360000000001
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00840336	0.8403360000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00840336	0.8403360000000001
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.8403360000000001
HEC SYNDROME	0.00840336	0.8403360000000001
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.8403360000000001
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.8403360000000001
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00840336	0.8403360000000001
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.8403360000000001
INFANTILE SIALIC ACID STORAGE DISEASE	0.00840336	0.8403360000000001
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.8403360000000001
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.8403360000000001
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.8403360000000001
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.8403360000000001
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.8403360000000001
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.8403360000000001
EBSTEIN MALFORMATION	0.00840336	0.8403360000000001
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.8403360000000001
CONGENITAL ANALBUMINEMIA	0.00840336	0.8403360000000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.00840336	0.8403360000000001
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.8403360000000001
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.8403360000000001
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.8403360000000001
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.8403360000000001
HYDROLETHALUS	0.00840336	0.8403360000000001
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.8403360000000001
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.8403360000000001
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.8403360000000001
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.8403360000000001
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00840336	0.8403360000000001
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.8403360000000001
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.8403360000000001
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.8403360000000001
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.8403360000000001
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.8403360000000001
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00840336	0.8403360000000001
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00840336	0.8403360000000001
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.8403360000000001
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.8403360000000001
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00840336	0.8403360000000001
YUNIS-VARON SYNDROME	0.00840336	0.8403360000000001
VACTERL/VATER ASSOCIATION	0.00840336	0.8403360000000001
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.8403360000000001
OMPHALOCELE	0.00840336	0.8403360000000001
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00822174	0.822174
BUSCHKE-OLLENDORFF SYNDROME	0.00822174	0.822174
LOWRY-WOOD SYNDROME	0.00822174	0.822174
FAMILIAL MEDITERRANEAN FEVER	0.00797672	0.7976719999999999
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00797672	0.7976719999999999
GITELMAN SYNDROME	0.00797672	0.7976719999999999
ADDISON DISEASE	0.00797672	0.7976719999999999
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00797672	0.7976719999999999
ACUTE ADRENAL INSUFFICIENCY	0.00797672	0.7976719999999999
SHEEHAN SYNDROME	0.00797672	0.7976719999999999
TYPHOID	0.00797672	0.7976719999999999
ACUTE INTERMITTENT PORPHYRIA	0.00797672	0.7976719999999999
JUVENILE DERMATOMYOSITIS	0.00797672	0.7976719999999999
ADIPOSIS DOLOROSA	0.00797672	0.7976719999999999
HEREDITARY COPROPORPHYRIA	0.00797672	0.7976719999999999
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00797672	0.7976719999999999
POLYMYOSITIS	0.00797672	0.7976719999999999
ADIPOSIS DOLOROSA	0.00797672	0.7976719999999999
GITELMAN SYNDROME	0.00797672	0.7976719999999999
RHEUMATIC FEVER	0.00797672	0.7976719999999999
BETA-THALASSEMIA MAJOR	0.0075698499999999995	0.7569849999999999
GRANULOMATOSIS WITH POLYANGIITIS	0.0075698499999999995	0.7569849999999999
PRADER-WILLI-LIKE SYNDROME	0.0073878799999999994	0.738788
LOWE OCULOCEREBRORENAL SYNDROME	0.0073878799999999994	0.738788
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.0073878799999999994	0.738788
1P36 DELETION SYNDROME	0.0073878799999999994	0.738788
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00673599	0.673599
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00673599	0.673599
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00673599	0.673599
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00673599	0.673599
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00673599	0.673599
CHROMOSOME 1P36 DELETION SYNDROME	0.00673599	0.673599
MALT LYMPHOMA	0.00673599	0.673599
FABRY DISEASE	0.00505718	0.505718
LEGG-CALVÉ-PERTHES DISEASE	0.00505718	0.505718
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.00505718	0.505718
MEVALONIC ACIDURIA; MEVA	0.00505718	0.505718
SAGLIKER SYNDROME	0.00505718	0.505718
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00505718	0.505718
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00505718	0.505718
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00505718	0.505718
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00505718	0.505718
GM1 GANGLIOSIDOSIS	0.00505718	0.505718
NEURALGIC AMYOTROPHY	0.00505718	0.505718
FARBER DISEASE	0.00505718	0.505718
GAUCHER DISEASE	0.00505718	0.505718
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00505718	0.505718
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00505718	0.505718
ACROOSTEOLYSIS DOMINANT TYPE	0.00505718	0.505718
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00505718	0.505718
MARSHALL SYNDROME	0.00505718	0.505718
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00505718	0.505718
XERODERMA PIGMENTOSUM	0.00505718	0.505718
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00505718	0.505718
EIKEN SYNDROME	0.00505718	0.505718
MUCKLE-WELLS SYNDROME	0.00505718	0.505718
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00505718	0.505718
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00505718	0.505718
STICKLER SYNDROME	0.00505718	0.505718
MUCOLIPIDOSIS III GAMMA	0.00505718	0.505718
PAROXYSMAL COLD HEMOGLOBINURIA	0.00440529	0.440529
HEMOCHROMATOSIS TYPE 4	0.00440529	0.440529
MARBURG HEMORRHAGIC FEVER	0.00440529	0.440529
MICROSCOPIC POLYANGIITIS	0.00440529	0.440529
CONGENITAL PATELLA DISLOCATION	0.00440529	0.440529
CRYPTOGENIC ORGANIZING PNEUMONIA	0.00440529	0.440529
RELAPSING POLYCHONDRITIS	0.00440529	0.440529
HEMOPHILIA A	0.00440529	0.440529
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00440529	0.440529
POSTPOLIOMYELITIS SYNDROME	0.00440529	0.440529
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00440529	0.440529
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00440529	0.440529
POLYCYTHEMIA VERA	0.00440529	0.440529
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00440529	0.440529
REACTIVE ARTHRITIS	0.00440529	0.440529
DENGUE FEVER	0.00440529	0.440529
KIENBOCK DISEASE	0.00440529	0.440529
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00440529	0.440529
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00440529	0.440529
PSEUDOACHONDROPLASIA	0.00440529	0.440529
ARACHNOIDITIS	0.00440529	0.440529
PRIMARY FAMILIAL POLYCYTHEMIA	0.00440529	0.440529
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00440529	0.440529
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00440529	0.440529
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00440529	0.440529
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.00440529	0.440529
STICKLER SYNDROME TYPE 1	0.00440529	0.440529
VIRAL HEMORRHAGIC FEVER	0.00440529	0.440529
UPINGTON DISEASE	0.00440529	0.440529
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00440529	0.440529
PANDAS	0.00440529	0.440529
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00440529	0.440529
PIGMENTED VILLONODULAR SYNOVITIS	0.00440529	0.440529
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.00440529	0.440529
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.00440529	0.440529
TAKAYASU ARTERITIS	0.00440529	0.440529
BABESIOSIS	0.00440529	0.440529
WILSON DISEASE	0.00440529	0.440529
PSEUDOACHONDROPLASIA	0.00440529	0.440529
RIFT VALLEY FEVER	0.00440529	0.440529
BLAU SYNDROME	0.00440529	0.440529
EOSINOPHILIC FASCIITIS	0.00440529	0.440529
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.00440529	0.440529
SOMATOMAMMOTROPINOMA	0.00440529	0.440529
SYSTEMIC SCLEROSIS	0.00440529	0.440529
LOCALIZED SCLERODERMA	0.00440529	0.440529
RAT-BITE FEVER	0.00440529	0.440529
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00440529	0.440529
BEHÇET DISEASE	0.00440529	0.440529
PLAGUE	0.00440529	0.440529
THORACIC OUTLET SYNDROME	0.00440529	0.440529
PACHYDERMOPERIOSTOSIS	0.00440529	0.440529
WELLS SYNDROME	0.00440529	0.440529
OSTEOCHONDRITIS DISSECANS	0.00440529	0.440529
NASU-HAKOLA DISEASE	0.00440529	0.440529
LASSA FEVER	0.00440529	0.440529
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00440529	0.440529
COMPLEMENT COMPONENT C1R DEFICIENCY	0.00440529	0.440529
SEVERE HEMOPHILIA A	0.00440529	0.440529
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00440529	0.440529
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00440529	0.440529
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00440529	0.440529
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.00440529	0.440529
ALKAPTONURIA	0.00440529	0.440529
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.440529
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00440529	0.440529
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.440529
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.440529
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.440529
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00440529	0.440529
DERMATOMYOSITIS	0.00440529	0.440529
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.440529
RARE HEREDITARY HEMOCHROMATOSIS	0.00440529	0.440529
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00440529	0.440529
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.440529
SCLERODERMA	0.00440529	0.440529
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00440529	0.440529
AUTOIMMUNE HEPATITIS	0.00440529	0.440529
LEDDERHOSE DISEASE	0.00440529	0.440529
MIXED CONNECTIVE TISSUE DISEASE	0.00440529	0.440529
SITOSTEROLEMIA	0.00440529	0.440529
ADULT-ONSET STILL DISEASE	0.00440529	0.440529
KAWASAKI DISEASE	0.00440529	0.440529
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00440529	0.440529
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	0.00440529	0.440529
NAKAJO-NISHIMURA SYNDROME	0.00440529	0.440529
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.00440529	0.440529
YELLOW FEVER	0.00440529	0.440529
IMMUNOGLOBULIN A VASCULITIS	0.00440529	0.440529
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00440529	0.440529
HAND OSTEOARTHRITIS	0.00440529	0.440529
POLYARTERITIS NODOSA	0.00440529	0.440529
MAJEED SYNDROME	0.00440529	0.440529
STICKLER SYNDROME, TYPE III	0.00440529	0.440529
ERYTHEMA ELEVATUM DIUTINUM	0.00440529	0.440529
SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	0.00440529	0.440529
ACQUIRED PARTIAL LIPODYSTROPHY	0.00440529	0.440529
CHST3-RELATED SKELETAL DYSPLASIA	0.00440529	0.440529
CRANIO-OSTEOARTHROPATHY	0.00440529	0.440529
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00440529	0.440529
COMMON VARIABLE IMMUNODEFICIENCY	0.00440529	0.440529
CZECH DYSPLASIA, METATARSAL TYPE	0.00440529	0.440529
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.00440529	0.440529
CUTANEOUS SMALL VESSEL VASCULITIS	0.00440529	0.440529
MAJEED SYNDROME	0.00440529	0.440529
SAPHO SYNDROME	0.00440529	0.440529
UPINGTON DISEASE	0.00440529	0.440529
DESMOID TUMOR	0.00440529	0.440529
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00440529	0.440529
CHILBLAIN LUPUS 1	0.00440529	0.440529
MELORHEOSTOSIS	0.00440529	0.440529
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2	0.00440529	0.440529
WHIPPLE DISEASE	0.00440529	0.440529
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00440529	0.440529
ACROMEGALY	0.00440529	0.440529
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.00440529	0.440529
LEGIONELLOSIS	0.00440529	0.440529
CHRONIC GRAFT VERSUS HOST DISEASE	0.00440529	0.440529
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	0.00440529	0.440529
GIANT CELL ARTERITIS	0.00440529	0.440529
MACROPHAGIC MYOFASCIITIS	0.00440529	0.440529
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00440529	0.440529
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00440529	0.440529
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00440529	0.440529
CRYOGLOBULINEMIC VASCULITIS	0.00440529	0.440529
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00440529	0.440529
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.00440529	0.440529
PFAPA SYNDROME	0.00440529	0.440529
HYPER-IGD SYNDROME	0.00440529	0.440529
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00440529	0.440529
LYME DISEASE	0.00440529	0.440529
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00440529	0.440529
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00440529	0.440529
RELAPSING FEVER	0.00440529	0.440529
PYODERMA GANGRENOSUM	0.00440529	0.440529
ALKAPTONURIA	0.00440529	0.440529
JUVENILE IDIOPATHIC ARTHRITIS	0.00440529	0.440529
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00440529	0.440529
FELTY SYNDROME	0.00440529	0.440529
FAMILIAL COLD URTICARIA	0.00440529	0.440529
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.00440529	0.440529
COLD AGGLUTININ DISEASE	0.00440529	0.440529
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00440529	0.440529
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00440529	0.440529
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.00440529	0.440529
SCHNITZLER SYNDROME	0.00440529	0.440529
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00440529	0.440529
KIKUCHI-FUJIMOTO DISEASE	0.00440529	0.440529
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00440529	0.440529
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.00440529	0.440529
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.00440529	0.440529
LEPTOSPIROSIS	0.00440529	0.440529
MADELUNG DEFORMITY	0.00440529	0.440529
NEUROGENIC THORACIC OUTLET SYNDROME	0.00440529	0.440529
BUERGER DISEASE	0.00440529	0.440529
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.00440529	0.440529
LEISHMANIASIS	0.00440529	0.440529
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00440529	0.440529
PYLE DISEASE; PYL	0.00440529	0.440529
CONGENITAL HYPOTHYROIDISM	0.00422332	0.422332
MOWAT-WILSON SYNDROME	0.00422332	0.422332
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00422332	0.422332
SCHAAF-YANG SYNDROME; SHFYNG	0.00422332	0.422332
THYROID HYPOPLASIA	0.00422332	0.422332
WHITE-SUTTON SYNDROME; WHSUS	0.00422332	0.422332
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00422332	0.422332
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00422332	0.422332
TEMPLE-BARAITSER SYNDROME	0.00422332	0.422332
PROPIONIC ACIDEMIA	0.00422332	0.422332
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00422332	0.422332
COFFIN-SIRIS SYNDROME 6; CSS6	0.00422332	0.422332
RETT SYNDROME; RTT	0.00422332	0.422332
13Q12.3 MICRODELETION SYNDROME	0.00422332	0.422332
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00422332	0.422332
MOWAT-WILSON SYNDROME; MOWS	0.00422332	0.422332
SMITH-MAGENIS SYNDROME	0.00422332	0.422332
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00422332	0.422332
RUBINSTEIN-TAYBI SYNDROME	0.00422332	0.422332
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00422332	0.422332
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00422332	0.422332
FLOATING-HARBOR SYNDROME	0.00422332	0.422332
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00422332	0.422332
COFFIN-SIRIS SYNDROME 7; CSS7	0.00422332	0.422332
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00422332	0.422332
KLEEFSTRA SYNDROME	0.00422332	0.422332
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00422332	0.422332
FAMILIAL THYROID DYSHORMONOGENESIS	0.00422332	0.422332
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00422332	0.422332
MELAS	0.00422332	0.422332
DDOST-CDG	0.00422332	0.422332
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00422332	0.422332
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00422332	0.422332
NEPHROGENIC DIABETES INSIPIDUS	0.00422332	0.422332
ATHYREOSIS	0.00422332	0.422332
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.00422332	0.422332
NIEMANN-PICK DISEASE, TYPE A	0.00422332	0.422332
2Q23.1 MICRODELETION SYNDROME	0.00422332	0.422332
HIRSCHSPRUNG DISEASE	0.00422332	0.422332
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.00422332	0.422332
THYROID ECTOPIA	0.00422332	0.422332
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00422332	0.422332
TOWNES-BROCKS SYNDROME	0.00422332	0.422332
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00422332	0.422332
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00422332	0.422332
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00422332	0.422332
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00422332	0.422332
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00422332	0.422332
C SYNDROME	0.00422332	0.422332
SMITH-MAGENIS SYNDROME; SMS	0.00422332	0.422332
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00422332	0.422332
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00381645	0.381645
WAGR SYNDROME	0.00381645	0.381645
SCHWARTZ-JAMPEL SYNDROME	0.00381645	0.381645
COFFIN-SIRIS SYNDROME 1; CSS1	0.00381645	0.381645
GAPO SYNDROME	0.00381645	0.381645
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00381645	0.381645
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00381645	0.381645
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00381645	0.381645
COFFIN-SIRIS SYNDROME 4; CSS4	0.00381645	0.381645
COFFIN-SIRIS SYNDROME 3; CSS3	0.00381645	0.381645
COFFIN-SIRIS SYNDROME 2; CSS2	0.00381645	0.381645
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00381645	0.381645
CYSTINOSIS	0.00381645	0.381645
RFT1-CDG	0.00381645	0.381645
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00381645	0.381645
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00381645	0.381645
TRIPLE A SYNDROME	0.00381645	0.381645
FETAL METHYLMERCURY SYNDROME	0.00381645	0.381645
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00381645	0.381645
COHEN SYNDROME	0.00381645	0.381645
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00381645	0.381645
FANCONI ANEMIA	0.00381645	0.381645
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00381645	0.381645
HELSMOORTEL-VAN DER AA SYNDROME	0.00381645	0.381645
ACRODERMATITIS ENTEROPATHICA	0.00381645	0.381645
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00381645	0.381645
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00381645	0.381645
NEONATAL ADRENOLEUKODYSTROPHY	0.00381645	0.381645
FOUNTAIN SYNDROME	0.00381645	0.381645
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00381645	0.381645
GOLDENHAR SYNDROME	0.00381645	0.381645
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00381645	0.381645
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00381645	0.381645
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00381645	0.381645
MICROPHTHALMIA, LENZ TYPE	0.00381645	0.381645
CONGENITAL RUBELLA SYNDROME	0.00381645	0.381645
OSTEOGENESIS IMPERFECTA	0.00381645	0.381645
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00381645	0.381645
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00381645	0.381645
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00381645	0.381645
NEUROFIBROMATOSIS TYPE 1	0.00381645	0.381645
BONNEMANN-MEINECKE-REICH SYNDROME	0.00381645	0.381645
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00381645	0.381645
AYMÉ-GRIPP SYNDROME	0.00381645	0.381645
INCONTINENTIA PIGMENTI	0.00381645	0.381645
MULTIPLE SULFATASE DEFICIENCY	0.00381645	0.381645
COFS SYNDROME	0.00381645	0.381645
MUCOLIPIDOSIS TYPE III	0.00381645	0.381645
VOGT-KOYANAGI-HARADA DISEASE	0.00381645	0.381645
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00381645	0.381645
CHROMOSOME XP11.3 DELETION SYNDROME	0.00381645	0.381645
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00381645	0.381645
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.357143
VISCERAL MYOPATHY; VSCM	0.00357143	0.357143
HINMAN SYNDROME	0.00357143	0.357143
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.00357143	0.357143
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.357143
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00357143	0.357143
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00357143	0.357143
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00357143	0.357143
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00357143	0.357143
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00357143	0.357143
MULTIPLE SYSTEM ATROPHY	0.00357143	0.357143
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00357143	0.357143
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.00357143	0.357143
PORPHYRIA VARIEGATA	0.00357143	0.357143
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.357143
ATTRV30M AMYLOIDOSIS	0.00357143	0.357143
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00357143	0.357143
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00357143	0.357143
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.357143
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00357143	0.357143
PANHYPOPITUITARISM	0.00357143	0.357143
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.357143
AU-KLINE SYNDROME; AUKS	0.00357143	0.357143
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.357143
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.00357143	0.357143
PARATHYROID CARCINOMA	0.00357143	0.357143
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00357143	0.357143
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00357143	0.357143
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00357143	0.357143
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00357143	0.357143
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00357143	0.357143
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00357143	0.357143
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00357143	0.357143
CAP POLYPOSIS	0.00357143	0.357143
INFANT BOTULISM	0.00357143	0.357143
LYNCH SYNDROME	0.00357143	0.357143
HOLOPROSENCEPHALY 2; HPE2	0.00357143	0.357143
UROFACIAL SYNDROME 2	0.00357143	0.357143
AUTISM, SUSCEPTIBILITY TO, 18	0.00357143	0.357143
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.00357143	0.357143
NEUROFERRITINOPATHY	0.00357143	0.357143
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.357143
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00357143	0.357143
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.357143
XQ28 (MECP2) DUPLICATION	0.00357143	0.357143
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00357143	0.357143
WOUND BOTULISM	0.00357143	0.357143
BOTULISM	0.00357143	0.357143
WAARDENBURG-SHAH SYNDROME	0.00357143	0.357143
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00357143	0.357143
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00357143	0.357143
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00357143	0.357143
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00357143	0.357143
DESANTO-SHINAWI SYNDROME	0.00357143	0.357143
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.357143
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.357143
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.357143
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.357143
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00357143	0.357143
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.357143
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.00357143	0.357143
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00357143	0.357143
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.357143
PAROXYSMAL EXTREME PAIN DISORDER	0.00357143	0.357143
PSEUDOMYXOMA PERITONEI	0.00357143	0.357143
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.357143
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00357143	0.357143
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.357143
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.357143
FAMILIAL COLORECTAL CANCER TYPE X	0.00357143	0.357143
UROFACIAL SYNDROME	0.00357143	0.357143
PURE AUTONOMIC FAILURE	0.00357143	0.357143
19P13.3 MICRODUPLICATION SYNDROME	0.00357143	0.357143
OCHOA SYNDROME	0.00357143	0.357143
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.357143
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.357143
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00357143	0.357143
TRISOMY 8P	0.00357143	0.357143
HYPOPHOSPHATASIA, INFANTILE	0.00357143	0.357143
NK-CELL ENTEROPATHY	0.00357143	0.357143
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00357143	0.357143
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00357143	0.357143
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.357143
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00357143	0.357143
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.00357143	0.357143
EMANUEL SYNDROME	0.00357143	0.357143
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00357143	0.357143
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00357143	0.357143
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00357143	0.357143
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00357143	0.357143
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00357143	0.357143
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00357143	0.357143
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.357143
INHALATIONAL BOTULISM	0.00357143	0.357143
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.00357143	0.357143
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.00357143	0.357143
SOMATOSTATINOMA	0.00357143	0.357143
GLUCAGONOMA	0.00357143	0.357143
PROPIONIC ACIDEMIA	0.00357143	0.357143
WOLFRAM SYNDROME	0.00357143	0.357143
PPOMA	0.00357143	0.357143
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.357143
PUDENDAL NEURALGIA	0.00357143	0.357143
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.357143
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.00357143	0.357143
GRFOMA	0.00357143	0.357143
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00357143	0.357143
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.00357143	0.357143
PITT-HOPKINS SYNDROME	0.00357143	0.357143
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.357143
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00357143	0.357143
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00357143	0.357143
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.00357143	0.357143
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00357143	0.357143
ALEXANDER DISEASE	0.00357143	0.357143
PRUNE BELLY SYNDROME	0.00357143	0.357143
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.357143
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.357143
KAPUR-TORIELLO SYNDROME	0.00357143	0.357143
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00357143	0.357143
PORPHYRIA	0.00357143	0.357143
IATROGENIC BOTULISM	0.00357143	0.357143
MYXEDEMA	0.00357143	0.357143
KAPUR-TORIELLO SYNDROME	0.00357143	0.357143
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00357143	0.357143
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00357143	0.357143
PITT-HOPKINS SYNDROME	0.00357143	0.357143
LIDDLE SYNDROME	0.00357143	0.357143
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.357143
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.357143
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.357143
611961 STEVENSON-CAREY SYNDROME	0.00357143	0.357143
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00357143	0.357143
ANGELMAN SYNDROME	0.00357143	0.357143
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.357143
HOLOPROSENCEPHALY	0.00357143	0.357143
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.357143
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.357143
PORPHYRIA VARIEGATA	0.00357143	0.357143
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00357143	0.357143
FOODBORNE BOTULISM	0.00357143	0.357143
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.357143
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00357143	0.357143
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00357143	0.357143
ERYTHERMALGIA, PRIMARY	0.00357143	0.357143
INFANTILE DYSTONIA-PARKINSONISM	0.00357143	0.357143
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.357143
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.357143
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.357143
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.357143
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00357143	0.357143
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.00357143	0.357143
RETT SYNDROME, CONGENITAL VARIANT	0.00357143	0.357143
HEREDITARY FRUCTOSE INTOLERANCE	0.00357143	0.357143
FG SYNDROME 2; FGS2	0.00357143	0.357143
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.357143
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00357143	0.357143
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00357143	0.357143
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00357143	0.357143
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.357143
THYROID HEMIAGENESIS	0.00357143	0.357143
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00357143	0.357143
AICARDI SYNDROME	0.00357143	0.357143
PERIPHERAL HYPOTHYROIDISM	0.00357143	0.357143
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00316456	0.31645599999999996
OCULOCUTANEOUS ALBINISM	0.00316456	0.31645599999999996
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.31645599999999996
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.31645599999999996
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00316456	0.31645599999999996
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.31645599999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00316456	0.31645599999999996
STEVENS-JOHNSON SYNDROME	0.00316456	0.31645599999999996
MUSCLE-EYE-BRAIN DISEASE	0.00316456	0.31645599999999996
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.31645599999999996
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.31645599999999996
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00316456	0.31645599999999996
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.31645599999999996
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.31645599999999996
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.31645599999999996
BAKER-GORDON SYNDROME; BAGOS	0.00316456	0.31645599999999996
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00316456	0.31645599999999996
KALLMANN SYNDROME	0.00316456	0.31645599999999996
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00316456	0.31645599999999996
ABLEPHARON MACROSTOMIA SYNDROME	0.00316456	0.31645599999999996
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00316456	0.31645599999999996
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00316456	0.31645599999999996
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00316456	0.31645599999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00316456	0.31645599999999996
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.31645599999999996
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00316456	0.31645599999999996
ATAXIA WITH VITAMIN E DEFICIENCY	0.00316456	0.31645599999999996
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00316456	0.31645599999999996
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00316456	0.31645599999999996
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00316456	0.31645599999999996
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.31645599999999996
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00316456	0.31645599999999996
KRABBE DISEASE	0.00316456	0.31645599999999996
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00316456	0.31645599999999996
MOEBIUS SYNDROME	0.00316456	0.31645599999999996
JABERI-ELAHI SYNDROME; JABELS	0.00316456	0.31645599999999996
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00316456	0.31645599999999996
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.31645599999999996
MARFAN SYNDROME	0.00316456	0.31645599999999996
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00316456	0.31645599999999996
FLYNN-AIRD SYNDROME	0.00316456	0.31645599999999996
MANGANESE POISONING	0.00316456	0.31645599999999996
ERDHEIM-CHESTER DISEASE	0.00316456	0.31645599999999996
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00316456	0.31645599999999996
APERT SYNDROME	0.00316456	0.31645599999999996
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00316456	0.31645599999999996
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.31645599999999996
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.31645599999999996
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.31645599999999996
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.31645599999999996
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00316456	0.31645599999999996
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.31645599999999996
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.31645599999999996
BLUE CONE MONOCHROMATISM	0.00316456	0.31645599999999996
FISH-EYE DISEASE	0.00316456	0.31645599999999996
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00316456	0.31645599999999996
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.31645599999999996
N SYNDROME	0.00316456	0.31645599999999996
CRANIOTELENCEPHALIC DYSPLASIA	0.00316456	0.31645599999999996
16Q24.3 MICRODELETION SYNDROME	0.00316456	0.31645599999999996
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.31645599999999996
TREACHER-COLLINS SYNDROME	0.00316456	0.31645599999999996
CARTILAGE-HAIR HYPOPLASIA	0.00316456	0.31645599999999996
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00316456	0.31645599999999996
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.31645599999999996
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.31645599999999996
HALLERMANN-STREIFF SYNDROME	0.00316456	0.31645599999999996
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.31645599999999996
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.00316456	0.31645599999999996
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00316456	0.31645599999999996
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00316456	0.31645599999999996
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.31645599999999996
SCHINZEL-GIEDION SYNDROME	0.00316456	0.31645599999999996
JALILI SYNDROME	0.00316456	0.31645599999999996
BROOKE-SPIEGLER SYNDROME	0.00316456	0.31645599999999996
CONE ROD DYSTROPHY	0.00316456	0.31645599999999996
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.31645599999999996
X-LINKED RETINAL DYSPLASIA	0.00316456	0.31645599999999996
AGEL AMYLOIDOSIS	0.00316456	0.31645599999999996
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.31645599999999996
2P15P16.1 MICRODELETION SYNDROME	0.00316456	0.31645599999999996
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00316456	0.31645599999999996
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00316456	0.31645599999999996
PETERS PLUS SYNDROME	0.00316456	0.31645599999999996
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00316456	0.31645599999999996
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.31645599999999996
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.00316456	0.31645599999999996
2Q23.1 MICRODUPLICATION SYNDROME	0.00316456	0.31645599999999996
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.31645599999999996
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.31645599999999996
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00316456	0.31645599999999996
RENAL COLOBOMA SYNDROME	0.00316456	0.31645599999999996
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.31645599999999996
MMEP SYNDROME	0.00316456	0.31645599999999996
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.31645599999999996
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00316456	0.31645599999999996
NEUROFIBROMATOSIS TYPE 2	0.00316456	0.31645599999999996
INFANTILE NEUROAXONAL DYSTROPHY	0.00316456	0.31645599999999996
GALACTOSEMIA	0.00316456	0.31645599999999996
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00316456	0.31645599999999996
ASCHER SYNDROME	0.00316456	0.31645599999999996
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.31645599999999996
CHYLOMICRON RETENTION DISEASE	0.00316456	0.31645599999999996
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.31645599999999996
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00316456	0.31645599999999996
UNILATERAL POLYMICROGYRIA	0.00316456	0.31645599999999996
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.31645599999999996
OCULODENTODIGITAL DYSPLASIA	0.00316456	0.31645599999999996
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00316456	0.31645599999999996
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.00316456	0.31645599999999996
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.31645599999999996
PAPILLOMA OF CHOROID PLEXUS	0.00316456	0.31645599999999996
OCULAR ALBINISM	0.00316456	0.31645599999999996
BRADYOPSIA	0.00316456	0.31645599999999996
ABETALIPOPROTEINEMIA	0.00316456	0.31645599999999996
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.31645599999999996
CADASIL	0.00316456	0.31645599999999996
PROLIDASE DEFICIENCY	0.00316456	0.31645599999999996
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00316456	0.31645599999999996
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.31645599999999996
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00316456	0.31645599999999996
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00316456	0.31645599999999996
PEROXISOME BIOGENESIS DISORDER 6B	0.00316456	0.31645599999999996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.31645599999999996
PEROXISOME BIOGENESIS DISORDER 5B	0.00316456	0.31645599999999996
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00316456	0.31645599999999996
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00316456	0.31645599999999996
SPASTIC PARAPLEGIA 16, X-LINKED	0.00316456	0.31645599999999996
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00316456	0.31645599999999996
JOUBERT SYNDROME 3; JBTS3	0.00316456	0.31645599999999996
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00316456	0.31645599999999996
HYPERTRYPTOPHANEMIA; HYPTRP	0.00316456	0.31645599999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00316456	0.31645599999999996
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.31645599999999996
JOUBERT SYNDROME 2	0.00316456	0.31645599999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00316456	0.31645599999999996
FILIPPI SYNDROME; FLPIS	0.00316456	0.31645599999999996
CONE DYSTROPHY 4	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00316456	0.31645599999999996
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00316456	0.31645599999999996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00316456	0.31645599999999996
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.31645599999999996
FUMARASE DEFICIENCY; FMRD	0.00316456	0.31645599999999996
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00316456	0.31645599999999996
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00316456	0.31645599999999996
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00316456	0.31645599999999996
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.31645599999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00316456	0.31645599999999996
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00316456	0.31645599999999996
RETINAL CONE DYSTROPHY 4	0.00316456	0.31645599999999996
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00316456	0.31645599999999996
GILLESPIE SYNDROME; GLSP	0.00316456	0.31645599999999996
TANGIER DISEASE; TGD	0.00316456	0.31645599999999996
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.31645599999999996
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.31645599999999996
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00316456	0.31645599999999996
BLUE CONE MONOCHROMACY; BCM	0.00316456	0.31645599999999996
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00316456	0.31645599999999996
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00316456	0.31645599999999996
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00316456	0.31645599999999996
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00316456	0.31645599999999996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00316456	0.31645599999999996
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00316456	0.31645599999999996
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.31645599999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00316456	0.31645599999999996
CONE-ROD DYSTROPHY 17; CORD17	0.00316456	0.31645599999999996
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00316456	0.31645599999999996
ALBINISM, OCULAR, TYPE I	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00316456	0.31645599999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00316456	0.31645599999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00316456	0.31645599999999996
N SYNDROME	0.00316456	0.31645599999999996
HEART AND BRAIN MALFORMATION SYNDROME	0.00316456	0.31645599999999996
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00316456	0.31645599999999996
CROUZON SYNDROME	0.00316456	0.31645599999999996
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.31645599999999996
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00316456	0.31645599999999996
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.31645599999999996
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.31645599999999996
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00316456	0.31645599999999996
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00316456	0.31645599999999996
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.31645599999999996
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.31645599999999996
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00316456	0.31645599999999996
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.31645599999999996
RETINITIS PIGMENTOSA 20	0.00316456	0.31645599999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00316456	0.31645599999999996
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00316456	0.31645599999999996
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.31645599999999996
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00316456	0.31645599999999996
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.31645599999999996
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00316456	0.31645599999999996
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.31645599999999996
RETINITIS PIGMENTOSA 27; RP27	0.00316456	0.31645599999999996
MUCOLIPIDOSIS IV; ML4	0.00316456	0.31645599999999996
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00316456	0.31645599999999996
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00316456	0.31645599999999996
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.065189
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.065189
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00065189	0.065189
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00065189	0.065189
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00065189	0.065189
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00065189	0.065189
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00065189	0.065189
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00065189	0.065189
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00065189	0.065189
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00065189	0.065189
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED 84	0.00065189	0.065189
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.065189
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.065189
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.065189
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00065189	0.065189
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00065189	0.065189
ROTHMUND-THOMSON SYNDROME	0.00065189	0.065189
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.065189
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00065189	0.065189
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED 99	0.00065189	0.065189
HYPOPHOSPHATASIA	0.00065189	0.065189
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.065189
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00065189	0.065189
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS	0.00065189	0.065189
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00065189	0.065189
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00065189	0.065189
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.00065189	0.065189
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.00065189	0.065189
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.00065189	0.065189
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00065189	0.065189
RAINE SYNDROME	0.00065189	0.065189
OGDEN SYNDROME; OGDNS	0.00065189	0.065189
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED 92	0.00065189	0.065189
260150 PALANT CLEFT PALATE SYNDROME	0.00065189	0.065189
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00065189	0.065189
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00065189	0.065189
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.00065189	0.065189
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00065189	0.065189
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00065189	0.065189
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00065189	0.065189
MERRF	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED 45	0.00065189	0.065189
PYCNODYSOSTOSIS	0.00065189	0.065189
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00065189	0.065189
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00065189	0.065189
SPONDYLOPERIPHERAL DYSPLASIA	0.00065189	0.065189
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00065189	0.065189
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.065189
SONODA SYNDROME	0.00065189	0.065189
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00065189	0.065189
SJOGREN-LARSSON SYNDROME; SLS	0.00065189	0.065189
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00065189	0.065189
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.065189
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.00065189	0.065189
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00065189	0.065189
BRADDOCK SYNDROME	0.00065189	0.065189
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00065189	0.065189
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00065189	0.065189
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00065189	0.065189
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00065189	0.065189
AICARDI-GOUTIÈRES SYNDROME	0.00065189	0.065189
LARSEN SYNDROME	0.00065189	0.065189
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00065189	0.065189
SACCHAROPINURIA	0.00065189	0.065189
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00065189	0.065189
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00065189	0.065189
LEPRECHAUNISM	0.00065189	0.065189
RODRIGUES BLINDNESS	0.00065189	0.065189
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00065189	0.065189
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00065189	0.065189
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.065189
BRANCHIOGENIC DEAFNESS SYNDROME	0.00065189	0.065189
TEEBI-SHALTOUT SYNDROME; TBSH	0.00065189	0.065189
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.00065189	0.065189
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00065189	0.065189
RAPADILINO SYNDROME	0.00065189	0.065189
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00065189	0.065189
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00065189	0.065189
ATKIN-FLAITZ SYNDROME	0.00065189	0.065189
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED 2	0.00065189	0.065189
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00065189	0.065189
LESCH-NYHAN SYNDROME; LNS	0.00065189	0.065189
PYGMY	0.00065189	0.065189
X-LINKED AGAMMAGLOBULINEMIA	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.00065189	0.065189
RAMON SYNDROME	0.00065189	0.065189
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00065189	0.065189
JEUNE SYNDROME	0.00065189	0.065189
OROFACIODIGITAL SYNDROME VI	0.00065189	0.065189
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00065189	0.065189
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00065189	0.065189
KID SYNDROME	0.00065189	0.065189
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00065189	0.065189
DENT DISEASE 1	0.00065189	0.065189
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00065189	0.065189
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00065189	0.065189
WERNER SYNDROME; WRN	0.00065189	0.065189
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00065189	0.065189
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00065189	0.065189
XQ25 MICRODUPLICATION SYNDROME	0.00065189	0.065189
RIDDLE SYNDROME	0.00065189	0.065189
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.00065189	0.065189
MEND SYNDROME; MEND	0.00065189	0.065189
APPARENT MINERALOCORTICOID EXCESS	0.00065189	0.065189
MULTIPLE OSTEOCHONDROMAS	0.00065189	0.065189
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.065189
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00065189	0.065189
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00065189	0.065189
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.00065189	0.065189
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00065189	0.065189
STIMMLER SYNDROME	0.00065189	0.065189
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00065189	0.065189
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.00065189	0.065189
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00065189	0.065189
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.065189
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.065189
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00065189	0.065189
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.065189
ERYTHROKERATODERMIA VARIABILIS	0.00065189	0.065189
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00065189	0.065189
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00065189	0.065189
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00065189	0.065189
THALIDOMIDE EMBRYOPATHY	0.00065189	0.065189
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.065189
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00065189	0.065189
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.065189
KENNERKNECHT SYNDROME	0.00065189	0.065189
HOYERAAL-HREIDARSSON SYNDROME	0.00065189	0.065189
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00065189	0.065189
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00065189	0.065189
9P13 MICRODELETION SYNDROME	0.00065189	0.065189
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00065189	0.065189
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.065189
AYME-GRIPP SYNDROME; AYGRP	0.00065189	0.065189
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00065189	0.065189
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00065189	0.065189
GURRIERI SYNDROME	0.00065189	0.065189
CLASSIC MULTIMINICORE MYOPATHY	0.00065189	0.065189
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00065189	0.065189
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00065189	0.065189
SENIOR-LOKEN SYNDROME	0.00065189	0.065189
COSTELLO SYNDROME	0.00065189	0.065189
OXOGLUTARIC ACIDURIA	0.00065189	0.065189
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00065189	0.065189
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00065189	0.065189
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.065189
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.00065189	0.065189
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00065189	0.065189
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00065189	0.065189
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00065189	0.065189
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00065189	0.065189
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00065189	0.065189
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00065189	0.065189
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00065189	0.065189
RICHIERI COSTA-DA SILVA SYNDROME	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00065189	0.065189
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00065189	0.065189
LAMELLAR ICHTHYOSIS	0.00065189	0.065189
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.065189
SHOX-RELATED SHORT STATURE	0.00065189	0.065189
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00065189	0.065189
CEREBROFACIOARTICULAR SYNDROME	0.00065189	0.065189
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00065189	0.065189
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.065189
DUPLICATION OF THE PITUITARY GLAND	0.00065189	0.065189
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.065189
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00065189	0.065189
XQ12-Q13.3 DUPLICATION SYNDROME	0.00065189	0.065189
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00065189	0.065189
ULNAR-MAMMARY SYNDROME	0.00065189	0.065189
STUVE-WIEDEMANN SYNDROME	0.00065189	0.065189
SAY-BARBER-MILLER SYNDROME	0.00065189	0.065189
SATOYOSHI SYNDROME	0.00065189	0.065189
TRISOMY 18	0.00065189	0.065189
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.065189
URBAN-ROGERS-MEYER SYNDROME	0.00065189	0.065189
GLYCEROL KINASE DEFICIENCY; GKD	0.00065189	0.065189
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00065189	0.065189
GRISCELLI SYNDROME	0.00065189	0.065189
CRANIOFRONTONASAL SYNDROME; CFNS	0.00065189	0.065189
GORDON SYNDROME	0.00065189	0.065189
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00065189	0.065189
AARSKOG-SCOTT SYNDROME	0.00065189	0.065189
FOCAL DERMAL HYPOPLASIA; FDH	0.00065189	0.065189
XYLT1-CDG	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.065189
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00065189	0.065189
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.065189
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00065189	0.065189
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00065189	0.065189
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00065189	0.065189
INCONTINENTIA PIGMENTI; IP	0.00065189	0.065189
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00065189	0.065189
COFFIN-LOWRY SYNDROME; CLS	0.00065189	0.065189
MASA SYNDROME	0.00065189	0.065189
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00065189	0.065189
TONNE-KALSCHEUER SYNDROME; TOKAS	0.00065189	0.065189
XQ25 DUPLICATION SYNDROME	0.00065189	0.065189
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00065189	0.065189
ISOLATED GLYCEROL KINASE DEFICIENCY	0.00065189	0.065189
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.00065189	0.065189
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00065189	0.065189
MEND SYNDROME	0.00065189	0.065189
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00065189	0.065189
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00065189	0.065189
CHARGE-LIKE SYNDROME, X-LINKED	0.00065189	0.065189
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.00065189	0.065189
PRIMROSE SYNDROME; PRIMS	0.00065189	0.065189
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.065189
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00065189	0.065189
SATOYOSHI SYNDROME	0.00065189	0.065189
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00065189	0.065189
WIEACKER-WOLFF SYNDROME	0.00065189	0.065189
KEARNS-SAYRE SYNDROME; KSS	0.00065189	0.065189
YUNIS-VARON SYNDROME	0.00065189	0.065189
EIKEN SYNDROME	0.00065189	0.065189
WILSON-TURNER SYNDROME	0.00065189	0.065189
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.00065189	0.065189
WARBURG MICRO SYNDROME 1	0.00065189	0.065189
WEILL-MARCHESANI SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00065189	0.065189
CODAS SYNDROME	0.00065189	0.065189
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00065189	0.065189
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00065189	0.065189
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00065189	0.065189
DOUBLE OUTLET RIGHT VENTRICLE	0.00065189	0.065189
CHROMOSOME 2Q37 DELETION SYNDROME	0.00065189	0.065189
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.065189
WIDOW'S PEAK SYNDROME	0.00065189	0.065189
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00065189	0.065189
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.00065189	0.065189
ROIFMAN SYNDROME	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00065189	0.065189
MENKES DISEASE	0.00065189	0.065189
RENPENNING SYNDROME 1; RENS1	0.00065189	0.065189
DISTAL MONOSOMY 1Q	0.00065189	0.065189
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00065189	0.065189
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00065189	0.065189
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00065189	0.065189
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00065189	0.065189
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00065189	0.065189
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00065189	0.065189
SLC35A2-CDG	0.00065189	0.065189
OROFACIODIGITAL SYNDROME I; OFD1	0.00065189	0.065189
PELIZAEUS-MERZBACHER DISEASE	0.00065189	0.065189
SPASTIC PARAPARESIS AND DEAFNESS	0.00065189	0.065189
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.065189
OROFACIODIGITAL SYNDROME IX; OFD9	0.00065189	0.065189
THANATOPHORIC DYSPLASIA TYPE 2	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00065189	0.065189
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.065189
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00065189	0.065189
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00065189	0.065189
BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.065189
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00065189	0.065189
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00065189	0.065189
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00065189	0.065189
ABRUZZO-ERICKSON SYNDROME	0.00065189	0.065189
NAIL-PATELLA SYNDROME	0.00065189	0.065189
NEUROFIBROMATOSIS, TYPE I	0.00065189	0.065189
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.00065189	0.065189
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00065189	0.065189
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00065189	0.065189
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00065189	0.065189
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.00065189	0.065189
PELVISCAPULAR DYSPLASIA	0.00065189	0.065189
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00065189	0.065189
KABUKI SYNDROME 1	0.00065189	0.065189
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00065189	0.065189
KBG SYNDROME	0.00065189	0.065189
HURLER-SCHEIE SYNDROME	0.00065189	0.065189
HURLER SYNDROME	0.00065189	0.065189
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.065189
BRACHYDACTYLY TYPE A4	0.00065189	0.065189
BRACHYDACTYLY TYPE A1	0.00065189	0.065189
BRACHYDACTYLY TYPE E	0.00065189	0.065189
BRACHYDACTYLY TYPE C	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.065189
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.065189
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00065189	0.065189
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.065189
X-LINKED HYPOPHOSPHATEMIA	0.00065189	0.065189
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.065189
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00065189	0.065189
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00065189	0.065189
STIFF SKIN SYNDROME	0.00065189	0.065189
STORMORKEN SYNDROME; STRMK	0.00065189	0.065189
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00065189	0.065189
THORACOPELVIC DYSOSTOSIS	0.00065189	0.065189
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00065189	0.065189
THUMB DEFORMITY AND ALOPECIA	0.00065189	0.065189
DIGEORGE SYNDROME; DGS	0.00065189	0.065189
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.00065189	0.065189
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.065189
VELOCARDIOFACIAL SYNDROME	0.00065189	0.065189
TETRASOMY 12P	0.00065189	0.065189
TURNER SYNDROME	0.00065189	0.065189
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00065189	0.065189
SEPTOOPTIC DYSPLASIA	0.00065189	0.065189
SHPRINTZEN OMPHALOCELE SYNDROME	0.00065189	0.065189
SCHIZOPHRENIA 1; SCZD1	0.00065189	0.065189
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00065189	0.065189
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00065189	0.065189
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00065189	0.065189
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.065189
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00065189	0.065189
PRADER-WILLI SYNDROME; PWS	0.00065189	0.065189
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.065189
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00065189	0.065189
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00065189	0.065189
RADIAL-RENAL SYNDROME	0.00065189	0.065189
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.065189
RUVALCABA SYNDROME	0.00065189	0.065189
WERNER SYNDROME	0.00065189	0.065189
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.065189
SAY SYNDROME	0.00065189	0.065189
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00065189	0.065189
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00065189	0.065189
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00065189	0.065189
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00065189	0.065189
NEUTRAL LIPID STORAGE MYOPATHY	0.00065189	0.065189
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00065189	0.065189
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00065189	0.065189
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00065189	0.065189
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.00065189	0.065189
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA TYPE 13	0.00065189	0.065189
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00065189	0.065189
ADRENOMYODYSTROPHY	0.00065189	0.065189
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00065189	0.065189
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00065189	0.065189
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.065189
CORNELIA DE LANGE SYNDROME 1	0.00065189	0.065189
COXOAURICULAR SYNDROME	0.00065189	0.065189
BRACHYDACTYLY, TYPE A6	0.00065189	0.065189
PAGOD SYNDROME	0.00065189	0.065189
MONOSOMY X	0.00065189	0.065189
MOSAIC MONOSOMY X	0.00065189	0.065189
CAT-EYE SYNDROME (TYPE I)	0.00065189	0.065189
ERMINE PHENOTYPE	0.00065189	0.065189
2Q33.1 DELETION SYNDROME	0.00065189	0.065189
15Q24 RECURRENT MICRODELETION SYNDROME	0.00065189	0.065189
22Q11.2 DISTAL DELETION SYNDROME	0.00065189	0.065189
15Q13.3 MICRODELETION SYNDROME	0.00065189	0.065189
12Q14 MICRODELETION SYNDROME	0.00065189	0.065189
SMITH-MAGENIS SYNDROME	0.00065189	0.065189
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00065189	0.065189
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00065189	0.065189
AURICULOOSTEODYSPLASIA	0.00065189	0.065189
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00065189	0.065189
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00065189	0.065189
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00065189	0.065189
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00065189	0.065189
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00065189	0.065189
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00065189	0.065189
HAIRY ELBOWS	0.00065189	0.065189
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00065189	0.065189
PITUITARY STALK INTERRUPTION SYNDROME	0.00065189	0.065189
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00065189	0.065189
HYPERTELORISM, TEEBI TYPE; TBHS	0.00065189	0.065189
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.065189
ACRODYSOSTOSIS	0.00065189	0.065189
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.065189
CHROMOSOME 18P DELETION SYNDROME	0.00065189	0.065189
PALLISTER-HALL SYNDROME	0.00065189	0.065189
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00065189	0.065189
15Q24 MICRODELETION SYNDROME	0.00065189	0.065189
SMITH-FINEMAN-MYERS SYNDROME	0.00065189	0.065189
CARPENTER-WAZIRI SYNDROME	0.00065189	0.065189
JUBERG-MARSIDI SYNDROME	0.00065189	0.065189
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.065189
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00065189	0.065189
AROMATASE EXCESS SYNDROME	0.00065189	0.065189
EHLERS-DANLOS SYNDROME, TYPE I	0.00065189	0.065189
MYHRE SYNDROME	0.00065189	0.065189
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00065189	0.065189
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00065189	0.065189
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00065189	0.065189
KOOLEN-DE VRIES SYNDROME	0.00065189	0.065189
DISTAL MONOSOMY 12Q	0.00065189	0.065189
LATERAL MENINGOCELE SYNDROME	0.00065189	0.065189
EXOSTOSES, MULTIPLE, TYPE I	0.00065189	0.065189
DISTAL TRISOMY 5Q	0.00065189	0.065189
MOSAIC TRISOMY 8	0.00065189	0.065189
EXOSTOSES, MULTIPLE, TYPE II	0.00065189	0.065189
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00065189	0.065189
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.065189
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00065189	0.065189
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.065189
FLOATING-HARBOR SYNDROME	0.00065189	0.065189
SIALIDOSIS TYPE 2	0.00065189	0.065189
WATSON SYNDROME	0.00065189	0.065189
MUCOLIPIDOSIS TYPE II	0.00065189	0.065189
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00065189	0.065189
BARAITSER-WINTER SYNDROME 1; BRWS1	0.00065189	0.065189
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00065189	0.065189
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00065189	0.065189
JOHANSON-BLIZZARD SYNDROME; JBS	0.00065189	0.065189
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00065189	0.065189
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00065189	0.065189
245800 LAURENCE-MOON SYNDROME	0.00065189	0.065189
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
OHDO SYNDROME	0.00065189	0.065189
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.065189
PFEIFFER SYNDROME	0.00065189	0.065189
3MC SYNDROME 3	0.00065189	0.065189
MARINESCO-SJOGREN SYNDROME; MSS	0.00065189	0.065189
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00065189	0.065189
MCDONOUGH SYNDROME	0.00065189	0.065189
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00065189	0.065189
PRADER-WILLI SYNDROME	0.00065189	0.065189
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00065189	0.065189
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00065189	0.065189
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00065189	0.065189
HOLOPROSENCEPHALY 1; HPE1	0.00065189	0.065189
NIEMANN-PICK DISEASE TYPE B	0.00065189	0.065189
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00065189	0.065189
INFANTILE REFSUM DISEASE	0.00065189	0.065189
RABSON-MENDENHALL SYNDROME	0.00065189	0.065189
PYCNODYSOSTOSIS	0.00065189	0.065189
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.065189
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00065189	0.065189
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00065189	0.065189
X-LINKED EHLERS-DANLOS SYNDROME	0.00065189	0.065189
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00065189	0.065189
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00065189	0.065189
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.065189
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00065189	0.065189
HYPOPHOSPHATASIA, CHILDHOOD	0.00065189	0.065189
3C SYNDROME	0.00065189	0.065189
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.065189
ACROCRANIOFACIAL DYSOSTOSIS	0.00065189	0.065189
NEURAMINIDASE DEFICIENCY	0.00065189	0.065189
ACROCAPITOFEMORAL DYSPLASIA	0.00065189	0.065189
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.065189
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00065189	0.065189
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00065189	0.065189
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.065189
NASODIGITOACOUSTIC SYNDROME	0.00065189	0.065189
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00065189	0.065189
MULTIMINICORE MYOPATHY	0.00065189	0.065189
PALLISTER-HALL SYNDROME	0.00065189	0.065189
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00065189	0.065189
NAVAJO NEUROHEPATOPATHY	0.00065189	0.065189
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00065189	0.065189
OCULOPALATOCEREBRAL SYNDROME	0.00065189	0.065189
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00065189	0.065189
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00065189	0.065189
OROFACIODIGITAL SYNDROME IV; OFD4	0.00065189	0.065189
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00065189	0.065189
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00065189	0.065189
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00065189	0.065189
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.065189
HYALURONIDASE DEFICIENCY	0.00065189	0.065189
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00065189	0.065189
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00065189	0.065189
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00065189	0.065189
NIJMEGEN BREAKAGE SYNDROME	0.00065189	0.065189
CEDNIK SYNDROME	0.00065189	0.065189
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00065189	0.065189
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00065189	0.065189
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00065189	0.065189
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00065189	0.065189
MUCOLIPIDOSIS III ALPHA/BETA	0.00065189	0.065189
NOONAN SYNDROME	0.00065189	0.065189
NIJMEGEN BREAKAGE SYNDROME	0.00065189	0.065189
NARP SYNDROME	0.00065189	0.065189
RETT SYNDROME	0.00065189	0.065189
HARTNUP DISORDER	0.00065189	0.065189
JUVENILE POLYPOSIS OF INFANCY	0.00065189	0.065189
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00065189	0.065189
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00065189	0.065189
KEUTEL SYNDROME	0.00065189	0.065189
GENITOPATELLAR SYNDROME	0.00065189	0.065189
DYSSPONDYLOENCHONDROMATOSIS	0.00065189	0.065189
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00065189	0.065189
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.065189
BIEMOND SYNDROME II	0.00065189	0.065189
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00065189	0.065189
BANGSTAD SYNDROME	0.00065189	0.065189
SYNDROMIC DIARRHEA	0.00065189	0.065189
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00065189	0.065189
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.065189
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00065189	0.065189
C SYNDROME	0.00065189	0.065189
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00065189	0.065189
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.00065189	0.065189
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00065189	0.065189
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.065189
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00065189	0.065189
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00065189	0.065189
MICROPHTHALMIA, SYNDROMIC 3	0.00065189	0.065189
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00065189	0.065189
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00065189	0.065189
ASPARTYLGLUCOSAMINURIA; AGU	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00065189	0.065189
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00065189	0.065189
ISOLATED SPINA BIFIDA	0.00065189	0.065189
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00065189	0.065189
SJÖGREN-LARSSON SYNDROME	0.00065189	0.065189
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00065189	0.065189
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00065189	0.065189
SAETHRE-CHOTZEN SYNDROME	0.00065189	0.065189
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00065189	0.065189
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00065189	0.065189
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00065189	0.065189
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00065189	0.065189
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00065189	0.065189
FANCONI ANEMIA	0.00065189	0.065189
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00065189	0.065189
FOUNTAIN SYNDROME	0.00065189	0.065189
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00065189	0.065189
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE IA	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE IB	0.00065189	0.065189
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00065189	0.065189
TRICHOHEPATOENTERIC SYNDROME 1	0.00065189	0.065189
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00065189	0.065189
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00065189	0.065189
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00065189	0.065189
SIALIDOSIS TYPE 1	0.00065189	0.065189
SHWACHMAN-DIAMOND SYNDROME	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00065189	0.065189
SECKEL SYNDROME	0.00065189	0.065189
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00065189	0.065189
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00065189	0.065189
MARTSOLF SYNDROME	0.00065189	0.065189
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00065189	0.065189
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00065189	0.065189
ATYPICAL WERNER SYNDROME	0.00065189	0.065189
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00065189	0.065189
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00065189	0.065189
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00065189	0.065189
CROME SYNDROME	0.00065189	0.065189
RHYNS SYNDROME; RHYNS	0.00065189	0.065189
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00065189	0.065189
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.065189
CEREBROCOSTOMANDIBULAR SYNDROME	0.00065189	0.065189
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.00065189	0.065189
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00065189	0.065189
CAMPOMELIC DYSPLASIA	0.00065189	0.065189
LOEYS-DIETZ SYNDROME 5	0.00065189	0.065189
17Q11.2 MICRODUPLICATION SYNDROME	0.00065189	0.065189
CEREBROFACIOTHORACIC DYSPLASIA	0.00065189	0.065189
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00065189	0.065189
WILLIAMS-BEUREN SYNDROME (WBS)	0.00065189	0.065189
CATEL-MANZKE SYNDROME	0.00065189	0.065189
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00065189	0.065189
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.065189
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.00065189	0.065189
CHARGE SYNDROME	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00065189	0.065189
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00065189	0.065189
BIEMOND SYNDROME TYPE 2	0.00065189	0.065189
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.00065189	0.065189
NOONAN SYNDROME 8; NS8	0.00065189	0.065189
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
VICI SYNDROME	0.00065189	0.065189
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.065189
COOPER-JABS SYNDROME	0.00065189	0.065189
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.065189
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00065189	0.065189
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.065189
STEEL SYNDROME; STLS	0.00065189	0.065189
COFFIN-SIRIS SYNDROME	0.00065189	0.065189
CODAS SYNDROME	0.00065189	0.065189
CLEIDOCRANIAL DYSPLASIA	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00065189	0.065189
RING CHROMOSOME 7 SYNDROME	0.00065189	0.065189
RING CHROMOSOME 6 SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00065189	0.065189
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.065189
DESBUQUOIS DYSPLASIA 2; DBQD2	0.00065189	0.065189
COXOAURICULAR SYNDROME	0.00065189	0.065189
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00065189	0.065189
BLOOM SYNDROME	0.00065189	0.065189
BLACKFAN-DIAMOND ANEMIA	0.00065189	0.065189
BALLER-GEROLD SYNDROME	0.00065189	0.065189
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.065189
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00065189	0.065189
LARYNX ATRESIA	0.00065189	0.065189
ATRESIA OF SMALL INTESTINE	0.00065189	0.065189
ATKIN-FLAITZ SYNDROME	0.00065189	0.065189
CAREY-FINEMAN-ZITER SYNDROME	0.00065189	0.065189
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00065189	0.065189
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00065189	0.065189
IMMUNODEFICIENCY 36; IMD36	0.00065189	0.065189
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00065189	0.065189
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00065189	0.065189
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00065189	0.065189
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00065189	0.065189
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00065189	0.065189
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00065189	0.065189
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00065189	0.065189
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.00065189	0.065189
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00065189	0.065189
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00065189	0.065189
SECKEL SYNDROME 8; SCKL8	0.00065189	0.065189
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.00065189	0.065189
FEINGOLD SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00065189	0.065189
BRANCHIO-OCULO-FACIAL SYNDROME	0.00065189	0.065189
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00065189	0.065189
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00065189	0.065189
CULLER-JONES SYNDROME; CJS	0.00065189	0.065189
BOWEN-CONRADI SYNDROME	0.00065189	0.065189
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00065189	0.065189
CRANIODIAPHYSEAL DYSPLASIA	0.00065189	0.065189
PIERPONT SYNDROME	0.00065189	0.065189
17P11.2 MICRODUPLICATION SYNDROME	0.00065189	0.065189
TRISOMY 5P	0.00065189	0.065189
TRISOMY 4P	0.00065189	0.065189
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.00065189	0.065189
6Q16 MICRODELETION SYNDROME	0.00065189	0.065189
TRISOMY 18P	0.00065189	0.065189
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00065189	0.065189
PERRAULT SYNDROME 3	0.00065189	0.065189
DISTAL TRISOMY 14Q	0.00065189	0.065189
WOLCOTT-RALLISON SYNDROME	0.00065189	0.065189
TRISOMY 12P	0.00065189	0.065189
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00065189	0.065189
NON-DISTAL TRISOMY 10Q	0.00065189	0.065189
STICKLER SYNDROME, TYPE V; STL5	0.00065189	0.065189
CHROMOSOME 15Q25 DELETION SYNDROME	0.00065189	0.065189
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.00065189	0.065189
NATIVE AMERICAN MYOPATHY	0.00065189	0.065189
DISTAL TRISOMY 6P	0.00065189	0.065189
CRANIOECTODERMAL DYSPLASIA 3	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00065189	0.065189
TRISOMY XQ28	0.00065189	0.065189
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00065189	0.065189
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00065189	0.065189
DYSOSTOSIS, STANESCU TYPE	0.00065189	0.065189
PERIPHERAL DYSOSTOSIS	0.00065189	0.065189
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00065189	0.065189
FRONTOFACIONASAL DYSPLASIA	0.00065189	0.065189
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00065189	0.065189
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00065189	0.065189
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00065189	0.065189
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00065189	0.065189
DYSOSTEOSCLEROSIS	0.00065189	0.065189
DYSKERATOSIS CONGENITA	0.00065189	0.065189
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00065189	0.065189
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00065189	0.065189
DYSEQUILIBRIUM SYNDROME	0.00065189	0.065189
H SYNDROME	0.00065189	0.065189
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.065189
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
ANE SYNDROME	0.00065189	0.065189
MONOSOMY 18P	0.00065189	0.065189
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00065189	0.065189
DISTAL MONOSOMY 15Q	0.00065189	0.065189
DISTAL MONOSOMY 13Q	0.00065189	0.065189
MONOSOMY 13Q14	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00065189	0.065189
DISTAL MONOSOMY 10P	0.00065189	0.065189
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00065189	0.065189
ODONTOCHONDRODYSPLASIA	0.00065189	0.065189
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.065189
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00065189	0.065189
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00065189	0.065189
FAMILIAL BENIGN COPPER DEFICIENCY	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00065189	0.065189
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00065189	0.065189
CRANIOFACIAL DYSSYNOSTOSIS	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.00065189	0.065189
MONOSOMY 18Q	0.00065189	0.065189
WEILL-MARCHESANI SYNDROME 3	0.00065189	0.065189
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00065189	0.065189
ISOLATED OSTEOPOIKILOSIS	0.00065189	0.065189
FEINGOLD SYNDROME 2; FGLDS2	0.00065189	0.065189
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.065189
CRANIOECTODERMAL DYSPLASIA 4	0.00065189	0.065189
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.065189
XP22.3 MICRODELETION SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00065189	0.065189
CHROMOSOME 17Q12 DELETION SYNDROME	0.00065189	0.065189
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00065189	0.065189
MAFFUCCI SYNDROME	0.00065189	0.065189
DISTAL MONOSOMY 7Q36	0.00065189	0.065189
DISTAL MONOSOMY 3P	0.00065189	0.065189
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00065189	0.065189
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.065189
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00065189	0.065189
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00065189	0.065189
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00065189	0.065189
CHROMOSOME 1P35 DELETION SYNDROME	0.00065189	0.065189
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00065189	0.065189
OROFACIODIGITAL SYNDROME XVII	0.00065189	0.065189
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00065189	0.065189
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00065189	0.065189
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00065189	0.065189
COFFIN-SIRIS SYNDROME 5	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00065189	0.065189
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00065189	0.065189
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00065189	0.065189
IMMUNODEFICIENCY 55; IMD55	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00065189	0.065189
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00065189	0.065189
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00065189	0.065189
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00065189	0.065189
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00065189	0.065189
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00065189	0.065189
SAUL-WILSON SYNDROME; SWILS	0.00065189	0.065189
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00065189	0.065189
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00065189	0.065189
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00065189	0.065189
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.065189
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00065189	0.065189
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00065189	0.065189
JOUBERT SYNDROME 26	0.00065189	0.065189
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00065189	0.065189
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00065189	0.065189
LUSCAN-LUMISH SYNDROME; LLS	0.00065189	0.065189
LYMPHEDEMA, HEREDITARY, III	0.00065189	0.065189
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00065189	0.065189
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00065189	0.065189
MIRAGE SYNDROME; MIRAGE	0.00065189	0.065189
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00065189	0.065189
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00065189	0.065189
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00065189	0.065189
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00065189	0.065189
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.065189
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.00065189	0.065189
ANAUXETIC DYSPLASIA 2; ANXD2	0.00065189	0.065189
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00065189	0.065189
SIFRIM-HITZ-WEISS SYNDROME	0.00065189	0.065189
CHITAYAT SYNDROME	0.00065189	0.065189
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00065189	0.065189
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00065189	0.065189
OPTIC ATROPHY 11; OPA11	0.00065189	0.065189
DYSTONIA 28, CHILDHOOD-ONSET	0.00065189	0.065189
ZTTK SYNDROME; ZTTKS	0.00065189	0.065189
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.00065189	0.065189
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00065189	0.065189
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00065189	0.065189
MEIER-GORLIN SYNDROME 7	0.00065189	0.065189
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00065189	0.065189
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00065189	0.065189
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00065189	0.065189
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00065189	0.065189
AL KAISSI SYNDROME; ALKAS	0.00065189	0.065189
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.065189
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00065189	0.065189
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00065189	0.065189
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00065189	0.065189
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.065189
ALAZAMI-YUAN SYNDROME	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00065189	0.065189
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.00065189	0.065189
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00065189	0.065189
FRAXE INTELLECTUAL DISABILITY	0.00065189	0.065189
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00065189	0.065189
METAPHYSEAL ANADYSPLASIA	0.00065189	0.065189
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00065189	0.065189
RUIJS-AALFS SYNDROME; RJALS	0.00065189	0.065189
CEREBELLOFACIODENTAL SYNDROME	0.00065189	0.065189
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.00065189	0.065189
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.065189
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00065189	0.065189
ALOPECIA ANTIBODY DEFICIENCY	0.00065189	0.065189
2Q37 MICRODELETION SYNDROME	0.00065189	0.065189
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00065189	0.065189
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.065189
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00065189	0.065189
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00065189	0.065189
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00065189	0.065189
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00065189	0.065189
OVARIAN DYSGENESIS 4; ODG4	0.00065189	0.065189
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00065189	0.065189
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00065189	0.065189
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00065189	0.065189
SHELDON-HALL SYNDROME	0.00065189	0.065189
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.065189
AURICULOOSTEODYSPLASIA	0.00065189	0.065189
AREDYLD SYNDROME	0.00065189	0.065189
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00065189	0.065189
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00065189	0.065189
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.00065189	0.065189
BARTTER SYNDROME	0.00065189	0.065189
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00065189	0.065189
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00065189	0.065189
BARDET-BIEDL SYNDROME	0.00065189	0.065189
PENTASOMY X	0.00065189	0.065189
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00065189	0.065189
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00065189	0.065189
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00065189	0.065189
ATAXIA-TELANGIECTASIA	0.00065189	0.065189
CHOPS SYNDROME; CHOPS	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00065189	0.065189
NOONAN SYNDROME 10; NS10	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.00065189	0.065189
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00065189	0.065189
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00065189	0.065189
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00065189	0.065189
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00065189	0.065189
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00065189	0.065189
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.00065189	0.065189
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00065189	0.065189
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00065189	0.065189
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00065189	0.065189
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00065189	0.065189
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00065189	0.065189
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00065189	0.065189
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00065189	0.065189
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00065189	0.065189
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00065189	0.065189
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00065189	0.065189
POPOV-CHANG SYNDROME; POPCHAS	0.00065189	0.065189
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00065189	0.065189
NOONAN SYNDROME 11; NS11	0.00065189	0.065189
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00065189	0.065189
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00065189	0.065189
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00065189	0.065189
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00065189	0.065189
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00065189	0.065189
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00065189	0.065189
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00065189	0.065189
NOONAN SYNDROME 9; NS9	0.00065189	0.065189
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00065189	0.065189
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00065189	0.065189
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00065189	0.065189
17Q12 MICRODELETION SYNDROME	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00065189	0.065189
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00065189	0.065189
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00065189	0.065189
NAIL-PATELLA-LIKE RENAL DISEASE	0.00065189	0.065189
20P12.3 MICRODELETION SYNDROME	0.00065189	0.065189
TRISOMY 17P	0.00065189	0.065189
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00065189	0.065189
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00065189	0.065189
MOYNAHAN SYNDROME	0.00065189	0.065189
16P13.11 MICRODELETION SYNDROME	0.00065189	0.065189
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00065189	0.065189
16P11.2P12.2 MICRODELETION SYNDROME	0.00065189	0.065189
15Q14 MICRODELETION SYNDROME	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00065189	0.065189
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00065189	0.065189
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00065189	0.065189
XQ27.3Q28 DUPLICATION SYNDROME	0.00065189	0.065189
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00065189	0.065189
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.065189
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00065189	0.065189
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00065189	0.065189
NEUROFACIODIGITORENAL SYNDROME	0.00065189	0.065189
NATHALIE SYNDROME	0.00065189	0.065189
KEIPERT SYNDROME	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.065189
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00065189	0.065189
14Q22Q23 MICRODELETION SYNDROME	0.00065189	0.065189
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.065189
LARSEN-LIKE SYNDROME	0.00065189	0.065189
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00065189	0.065189
COG5-CDG	0.00065189	0.065189
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.00065189	0.065189
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00065189	0.065189
3M SYNDROME	0.00065189	0.065189
RING CHROMOSOME Y SYNDROME	0.00065189	0.065189
MULIBREY NANISM	0.00065189	0.065189
MOMO SYNDROME	0.00065189	0.065189
MELNICK-NEEDLES SYNDROME	0.00065189	0.065189
1Q41Q42 MICRODELETION SYNDROME	0.00065189	0.065189
6Q25 MICRODELETION SYNDROME	0.00065189	0.065189
2Q32Q33 MICRODELETION SYNDROME	0.00065189	0.065189
2Q31.1 MICRODELETION SYNDROME	0.00065189	0.065189
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00065189	0.065189
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00065189	0.065189
MICRO SYNDROME	0.00065189	0.065189
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00065189	0.065189
1Q21.1 MICRODELETION SYNDROME	0.00065189	0.065189
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00065189	0.065189
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00065189	0.065189
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00065189	0.065189
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.00065189	0.065189
ACROGERIA	0.00065189	0.065189
FRONTONASAL DYSPLASIA	0.00065189	0.065189
MESOMELIA-SYNOSTOSES SYNDROME	0.00065189	0.065189
KOOLEN-DE VRIES SYNDROME; KDVS	0.00065189	0.065189
8P11.2 DELETION SYNDROME	0.00065189	0.065189
8P23.1 MICRODELETION SYNDROME	0.00065189	0.065189
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00065189	0.065189
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.065189
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00065189	0.065189
BRUCK SYNDROME 2	0.00065189	0.065189
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.065189
CHROMOSOME 10Q26 DELETION SYNDROME	0.00065189	0.065189
FRIAS SYNDROME	0.00065189	0.065189
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.065189
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00065189	0.065189
NOONAN SYNDROME 3; NS3	0.00065189	0.065189
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00065189	0.065189
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00065189	0.065189
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00065189	0.065189
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00065189	0.065189
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00065189	0.065189
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00065189	0.065189
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00065189	0.065189
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.065189
MICROTRIPLICATION 11Q24.1	0.00065189	0.065189
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00065189	0.065189
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.065189
MICROHYDRANENCEPHALY; MHAC	0.00065189	0.065189
BOHRING-OPITZ SYNDROME	0.00065189	0.065189
MEVALONIC ACIDURIA	0.00065189	0.065189
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.065189
NOONAN SYNDROME 2; NS2	0.00065189	0.065189
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00065189	0.065189
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.065189
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00065189	0.065189
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00065189	0.065189
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.00065189	0.065189
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.065189
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00065189	0.065189
SHORT STATURE, BRUSSELS TYPE	0.00065189	0.065189
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00065189	0.065189
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.065189
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00065189	0.065189
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00065189	0.065189
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.065189
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00065189	0.065189
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00065189	0.065189
PSEUDOPROGERIA SYNDROME	0.00065189	0.065189
ACROOTOOCULAR SYNDROME	0.00065189	0.065189
GRACILE BONE DYSPLASIA; GCLEB	0.00065189	0.065189
LEUKOCYTE ADHESION DEFICIENCY	0.00065189	0.065189
PROGEROID SYNDROME, PETTY TYPE	0.00065189	0.065189
DE BARSY SYNDROME	0.00065189	0.065189
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00065189	0.065189
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00065189	0.065189
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00065189	0.065189
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00065189	0.065189
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.00065189	0.065189
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00065189	0.065189
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00065189	0.065189
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00065189	0.065189
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00065189	0.065189
HURLER SYNDROME	0.00065189	0.065189
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.065189
BRUCK SYNDROME	0.00065189	0.065189
HURLER-SCHEIE SYNDROME	0.00065189	0.065189
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00065189	0.065189
NIEMANN-PICK DISEASE, TYPE B	0.00065189	0.065189
OSLAM SYNDROME	0.00065189	0.065189
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00065189	0.065189
OROFACIODIGITAL SYNDROME TYPE 6	0.00065189	0.065189
OROFACIODIGITAL SYNDROME TYPE 2	0.00065189	0.065189
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00065189	0.065189
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00065189	0.065189
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00065189	0.065189
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00065189	0.065189
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00065189	0.065189
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.065189
OTOFACIOCERVICAL SYNDROME	0.00065189	0.065189
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
JUVENILE PAGET DISEASE	0.00065189	0.065189
SPONDYLOOCULAR SYNDROME; SOS	0.00065189	0.065189
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00065189	0.065189
XP22.13P22.2 DUPLICATION SYNDROME	0.00065189	0.065189
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00065189	0.065189
WRINKLY SKIN SYNDROME	0.00065189	0.065189
STIFF SKIN SYNDROME	0.00065189	0.065189
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00065189	0.065189
PARANA HARD SKIN SYNDROME	0.00065189	0.065189
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.00065189	0.065189
MONOSOMY 5P	0.00065189	0.065189
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.00065189	0.065189
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00065189	0.065189
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00065189	0.065189
SECKEL SYNDROME 2; SCKL2	0.00065189	0.065189
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00065189	0.065189
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
LISSENCEPHALY 4	0.00065189	0.065189
COLE-CARPENTER SYNDROME	0.00065189	0.065189
GEMIGNANI SYNDROME	0.00065189	0.065189
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.00065189	0.065189
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00065189	0.065189
FORSYTHE-WAKELING SYNDROME; FWS	0.00065189	0.065189
FRYNS-SMEETS-THIRY SYNDROME	0.00065189	0.065189
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00065189	0.065189
FREEMAN-SHELDON SYNDROME	0.00065189	0.065189
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00065189	0.065189
COWDEN SYNDROME	0.00065189	0.065189
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00065189	0.065189
SECKEL SYNDROME 4	0.00065189	0.065189
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.065189
FIBROCHONDROGENESIS	0.00065189	0.065189
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00065189	0.065189
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.065189
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00065189	0.065189
GERMAN SYNDROME	0.00065189	0.065189
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.00065189	0.065189
CUTIS LAXA	0.00065189	0.065189
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00065189	0.065189
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.065189
HENNEKAM-BEEMER SYNDROME	0.00065189	0.065189
NOONAN SYNDROME 6; NS6	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 10	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00065189	0.065189
HARTNUP DISEASE	0.00065189	0.065189
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.065189
HALL-RIGGS SYNDROME	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00065189	0.065189
WITTEVEEN-KOLK SYNDROME	0.00065189	0.065189
GRANT SYNDROME	0.00065189	0.065189
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00065189	0.065189
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00065189	0.065189
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00065189	0.065189
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.065189
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00065189	0.065189
EEC SYNDROME	0.00065189	0.065189
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00065189	0.065189
HIDROTIC ECTODERMAL DYSPLASIA	0.00065189	0.065189
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.065189
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE X	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00065189	0.065189
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00065189	0.065189
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.065189
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.00065189	0.065189
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00065189	0.065189
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.00065189	0.065189
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00065189	0.065189
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.065189
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.065189
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00065189	0.065189
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00065189	0.065189
COCKAYNE SYNDROME	0.00065189	0.065189
FETAL HYDANTOIN SYNDROME	0.00065189	0.065189
SECKEL SYNDROME 5; SCKL5	0.00065189	0.065189
NOONAN SYNDROME 7; NS7	0.00065189	0.065189
FEMORAL-FACIAL SYNDROME	0.00065189	0.065189
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00065189	0.065189
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.00065189	0.065189
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00065189	0.065189
EPILEPSY-TELANGIECTASIA SYNDROME	0.00065189	0.065189
CAT-EYE SYNDROME	0.00065189	0.065189
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00065189	0.065189
ENG-STROM SYNDROME	0.00065189	0.065189
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00065189	0.065189
COHEN SYNDROME	0.00065189	0.065189
TOLUENE EMBRYOPATHY	0.00065189	0.065189
COFFIN-LOWRY SYNDROME	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00065189	0.065189
FETAL ALCOHOL SYNDROME	0.00065189	0.065189
MACS SYNDROME	0.00065189	0.065189
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00065189	0.065189
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00065189	0.065189
SANJAD-SAKATI SYNDROME	0.00065189	0.065189
CONGENITAL LARYNGEAL WEB	0.00065189	0.065189
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE V	0.00065189	0.065189
KBG SYNDROME	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00065189	0.065189
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00065189	0.065189
KABUKI SYNDROME	0.00065189	0.065189
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00065189	0.065189
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00065189	0.065189
JOHANSON-BLIZZARD SYNDROME	0.00065189	0.065189
NOONAN SYNDROME 5; NS5	0.00065189	0.065189
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00065189	0.065189
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00065189	0.065189
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.00065189	0.065189
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00065189	0.065189
LAURENCE-MOON SYNDROME	0.00065189	0.065189
POTOCKI-LUPSKI SYNDROME	0.00065189	0.065189
15Q11Q13 MICRODUPLICATION SYNDROME	0.00065189	0.065189
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00065189	0.065189
MCKUSICK-KAUFMAN SYNDROME	0.00065189	0.065189
MCDONOUGH SYNDROME	0.00065189	0.065189
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00065189	0.065189
MASA SYNDROME	0.00065189	0.065189
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00065189	0.065189
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00065189	0.065189
NOONAN SYNDROME 4; NS4	0.00065189	0.065189
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
46,XX GONADAL DYSGENESIS	0.00065189	0.065189
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00065189	0.065189
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00065189	0.065189
CORNELIA DE LANGE SYNDROME 3	0.00065189	0.065189
CHOREOACANTHOCYTOSIS	0.00065189	0.065189
1Q44 MICRODELETION SYNDROME	0.00065189	0.065189
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.065189
HUNTER-MACDONALD SYNDROME	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00065189	0.065189
CONGENITAL SHORT BOWEL SYNDROME	0.00065189	0.065189
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00065189	0.065189
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00065189	0.065189
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 8	0.00065189	0.065189
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00065189	0.065189
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00065189	0.065189
PSEUDOAMINOPTERIN SYNDROME	0.00065189	0.065189
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00065189	0.065189
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00065189	0.065189
THREE M SYNDROME 2; 3M2	0.00065189	0.065189
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00065189	0.065189
HADZISELIMOVIC SYNDROME	0.00065189	0.065189
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00065189	0.065189
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00065189	0.065189
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00065189	0.065189
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.065189
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.065189
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00065189	0.065189
ARGININOSUCCINIC ACIDURIA	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 5	0.00065189	0.065189
ISOLATED AGAMMAGLOBULINEMIA	0.00065189	0.065189
5Q35 MICRODUPLICATION SYNDROME	0.00065189	0.065189
POLYVALVULAR HEART DISEASE SYNDROME	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.065189
FONTAINE PROGEROID SYNDROME; FPS	0.00065189	0.065189
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00065189	0.065189
GLASS SYNDROME	0.00065189	0.065189
ICF SYNDROME	0.00065189	0.065189
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00065189	0.065189
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00065189	0.065189
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00065189	0.065189
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00065189	0.065189
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00065189	0.065189
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 4	0.00065189	0.065189
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.065189
